Evidence map›Paper›PMID 35520855›Full record

ArticleRSC advances2020

Amplified piezoelectrically actuated on-chip flow switching for a rapid and stable microfluidic fluorescence activated cell sorter.

Kunpeng Cai, Shruti Mankar, Anastasia Maslova, Taiga Ajiri, Tasuku Yotoriyama

Abstract read
In one paragraph

Article in RSC advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Scaling Cultured Meat: Challenges and Solutions for Affordable Mass Production.Comprehensive reviews in food science and food safety · 2025
    Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kunpeng CaiCentral Research Laboratories, Sysmex Corporation 4-4-4 Takatsukadai, Nishi-ku Kobe 651-2271 Japan Cai.Kunpeng@sysmex.co.jp.ORCID https://orcid.org/0000-0003-2543-9661
Shruti MankarCentral Research Laboratories, Sysmex Corporation 4-4-4 Takatsukadai, Nishi-ku Kobe 651-2271 Japan Cai.Kunpeng@sysmex.co.jp.
Anastasia MaslovaCentral Research Laboratories, Sysmex Corporation 4-4-4 Takatsukadai, Nishi-ku Kobe 651-2271 Japan Cai.Kunpeng@sysmex.co.jp.ORCID https://orcid.org/0000-0002-1372-6842
Taiga AjiriCentral Research Laboratories, Sysmex Corporation 4-4-4 Takatsukadai, Nishi-ku Kobe 651-2271 Japan Cai.Kunpeng@sysmex.co.jp.
Tasuku YotoriyamaCentral Research Laboratories, Sysmex Corporation 4-4-4 Takatsukadai, Nishi-ku Kobe 651-2271 Japan Cai.Kunpeng@sysmex.co.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the potential to avoid cross-contamination, eliminate bio-aerosols, and minimize device footprints, microfluidic fluorescence-activated cell sorting (μ-FACS) devices could become the platform for the next generation cell sorter. Here, we report an on-chip flow switching based μ-FACS mechanism with piezoelectric actuation as a fast and robust sorting solution. A microfluidic chip with bifurcate configuration and displacement amplified piezoelectric microvalves has been developed to build the μ-FACS system. Rare fluorescent microparticles of different sizes have been significantly enriched from a purity of ∼0.5% to more than 90%. An enrichment of 150-fold from ∼0.6% to ∼91% has also been confirmed for fluorescently labeled MCF-7 breast cancer cells from Jurkat cells, while viability after sorting was maintained. Taking advantage of its simple structure, low cost, fast response, and reliable flow regulation, the proposed μ-FACS system delivers a new option that can meet the requirements of sorting performance, target selectivity, device lifetime, and cost-effectiveness of implementation.

Identifiers

PMID35520855
PMCPMC9057478

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.